Skip to main content
. 2019 Nov 4;2019:4659048. doi: 10.1155/2019/4659048

Figure 3.

Figure 3

Effect of the SIRI on the survival of adenocarcinoma of the oesophagogastric junction patients in stage I (a), stage II (b), and stage III (c).